James F. Oliviero III - 17 Jun 2022 Form 4 Insider Report for Checkpoint Therapeutics, Inc. (CKPT)

Role
CEO, President and Director, Director
Signature
/s/ James F. Oliviero, III
Issuer symbol
CKPT
Transactions as of
17 Jun 2022
Transactions value $
-$301,140
Form type
4
Filing time
01 Jul 2022, 21:30:35 UTC
Previous filing
05 Apr 2022
Next filing
12 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CKPT COMMON STOCK Sale -$249K -228K -8.03% $1.09 2.61M 17 Jun 2022 Direct F1, F2
transaction CKPT COMMON STOCK Sale -$22.9K -21K -0.8% $1.09 2.59M 21 Jun 2022 Direct F2, F3
transaction CKPT COMMON STOCK Sale -$13.1K -12K -0.46% $1.09 2.58M 22 Jun 2022 Direct F2, F4
transaction CKPT COMMON STOCK Sale -$16.7K -15K -0.58% $1.11 2.56M 23 Jun 2022 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.06 to $1.12. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
F2 Includes shares of restricted Common Stock, which vest over various time periods.
F3 Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.06 to $1.12. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
F4 Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.09 to $1.10. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
F5 Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.11 to $1.13. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.